Blumeatin

CAS No. 118024-26-3

Blumeatin ( —— )

Catalog No. M23347 CAS No. 118024-26-3

Blumeatin has antioxidant properties, free radical scavenging activity,and has xanthine oxidase (XO) inhibitory activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 372 In Stock
10MG 556 In Stock
25MG 887 In Stock
50MG 1197 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Blumeatin
  • Note
    Research use only, not for human use.
  • Brief Description
    Blumeatin has antioxidant properties, free radical scavenging activity,and has xanthine oxidase (XO) inhibitory activity.
  • Description
    Blumeatin has antioxidant properties, free radical scavenging activity,and has xanthine oxidase (XO) inhibitory activity.
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    ROS
  • Recptor
    XO
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    118024-26-3
  • Formula Weight
    302.3
  • Molecular Formula
    C16H14O6
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:250 mg/mL (827.05 mM; Need ultrasonic)
  • SMILES
    O=C1C[C@@H](C2=CC(O)=CC(O)=C2)OC3=CC(OC)=CC(O)=C13
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Free radical-scavenging activity of organic extracts and of pure flavonoids of Blumea balsamifera DC leaves.Food Chem., 2004, 88(2):243-52.
molnova catalog
related products
  • 8-Prenylnaringenin

    8-Prenylnaringenin is a phytoestrogen with high estrogenic activity,In vitro, aggregates of buccal epithelial cells were irradiated and cultured in suspension for 11 days.

  • Inosine

    A purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose.

  • Ophiopogonin D(b)

    Ophiopogonin D(OPD) significantly inhibited the in vitro and in vivo growth of prostate cells via RIPK1 OPD may be developed as a potential anti-prostate cancer agent.